125 related articles for article (PubMed ID: 28089627)
1. The Relationship Between Tamoxifen-associated Nonalcoholic Fatty Liver Disease and the Prognosis of Patients With Early-stage Breast Cancer.
Yan M; Wang J; Xuan Q; Dong T; He J; Zhang Q
Clin Breast Cancer; 2017 Jun; 17(3):195-203. PubMed ID: 28089627
[TBL] [Abstract][Full Text] [Related]
2. Selective Estrogen Receptor Modulator-Associated Nonalcoholic Fatty Liver Disease Improved Survival in Patients With Breast Cancer: A Retrospective Cohort Analysis.
Zheng Q; Xu F; Nie M; Xia W; Qin T; Qin G; An X; Xue C; Peng R; Yuan Z; Shi Y; Wang S
Medicine (Baltimore); 2015 Oct; 94(40):e1718. PubMed ID: 26448028
[TBL] [Abstract][Full Text] [Related]
3. Prevention of Tamoxifen-related Nonalcoholic Fatty Liver Disease in Breast Cancer Patients.
Chang HT; Pan HJ; Lee CH
Clin Breast Cancer; 2018 Aug; 18(4):e677-e685. PubMed ID: 29287963
[TBL] [Abstract][Full Text] [Related]
4. Aromatase Inhibitors and Newly Developed Nonalcoholic Fatty Liver Disease in Postmenopausal Patients with Early Breast Cancer: A Propensity Score-Matched Cohort Study.
Lee JI; Yu JH; Anh SG; Lee HW; Jeong J; Lee KS
Oncologist; 2019 Aug; 24(8):e653-e661. PubMed ID: 30679317
[TBL] [Abstract][Full Text] [Related]
5. Incidence and risk factors for non-alcoholic steatohepatitis in females treated with tamoxifen for breast cancer.
Akhondi-Meybodi M; Mortazavy-Zadah MR; Hashemian Z; Moaiedi M
Arab J Gastroenterol; 2011 Mar; 12(1):34-6. PubMed ID: 21429453
[TBL] [Abstract][Full Text] [Related]
6. Association between tamoxifen treatment and the development of different stages of nonalcoholic fatty liver disease among breast cancer patients.
Pan HJ; Chang HT; Lee CH
J Formos Med Assoc; 2016 Jun; 115(6):411-7. PubMed ID: 26071793
[TBL] [Abstract][Full Text] [Related]
7. Optimal systemic therapy for premenopausal women with hormone receptor-positive breast cancer.
Jankowitz RC; McGuire KP; Davidson NE
Breast; 2013 Aug; 22 Suppl 2():S165-70. PubMed ID: 24074781
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor, Progesterone receptor, HER2 status and Ki67 index and responsiveness to adjuvant tamoxifen in postmenopausal high-risk breast cancer patients enrolled in the DBCG 77C trial.
Knoop AS; Lænkholm AV; Jensen MB; Nielsen KV; Andersen J; Nielsen D; Ejlertsen B;
Eur J Cancer; 2014 May; 50(8):1412-21. PubMed ID: 24675287
[TBL] [Abstract][Full Text] [Related]
9. Different patterns in the risk of newly developed fatty liver and lipid changes with tamoxifen versus aromatase inhibitors in postmenopausal women with early breast cancer: A propensity score-matched cohort study.
Hong N; Yoon HG; Seo DH; Park S; Kim SI; Sohn JH; Rhee Y
Eur J Cancer; 2017 Sep; 82():103-114. PubMed ID: 28651157
[TBL] [Abstract][Full Text] [Related]
10. Competing Risks of Mortality by PAM50 Intrinsic Subtype of British Columbia Tamoxifen-Treated Cohort of Postmenopausal Patients With Breast Cancer.
Chapman JW; Liu S; Leung S; Nielsen TO
Clin Breast Cancer; 2017 Jul; 17(4):e215-e224. PubMed ID: 28365335
[TBL] [Abstract][Full Text] [Related]
11. Physical activity and survival of postmenopausal, hormone receptor-positive breast cancer patients: results of the Tamoxifen Exemestane Adjuvant Multicenter Lifestyle study.
de Glas NA; Fontein DB; Bastiaannet E; Pijpe A; De Craen AJ; Liefers GJ; Nortier HJ; de Haes HJ; van de Velde CJ; van Leeuwen FE
Cancer; 2014 Sep; 120(18):2847-54. PubMed ID: 24840230
[TBL] [Abstract][Full Text] [Related]
12. Association of nonalcoholic fatty liver disease with cardiovascular risk factors in obese adolescents: the role of interdisciplinary therapy.
Sanches PL; de Piano A; Campos RM; Carnier J; de Mello MT; Elias N; Fonseca FA; Masquio DC; da Silva PL; Corgosinho FC; Tock L; Oyama LM; Tufik S; Dâmaso AR
J Clin Lipidol; 2014; 8(3):265-72. PubMed ID: 24793347
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and risk factors of nonalcoholic fatty liver disease in breast cancer patients.
Lee S; Jung Y; Bae Y; Yun SP; Kim S; Jo H; Seo HI
Tumori; 2017 Mar; 103(2):187-192. PubMed ID: 27647227
[TBL] [Abstract][Full Text] [Related]
14. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
[TBL] [Abstract][Full Text] [Related]
15. Risk Factors for Tamoxifen-Induced Ovarian Hyperstimulation in Breast Cancer Patients.
Kim MK; Shin HC
Clin Breast Cancer; 2020 Oct; 20(5):408-412. PubMed ID: 32727665
[TBL] [Abstract][Full Text] [Related]
16. Ano1/TMEM16A Overexpression Is Associated with Good Prognosis in PR-Positive or HER2-Negative Breast Cancer Patients following Tamoxifen Treatment.
Wu H; Guan S; Sun M; Yu Z; Zhao L; He M; Zhao H; Yao W; Wang E; Jin F; Xiao Q; Wei M
PLoS One; 2015; 10(5):e0126128. PubMed ID: 25961581
[TBL] [Abstract][Full Text] [Related]
17. Prognostic role of human epidermal growth factor receptor 2 status in premenopausal early breast cancer treated with adjuvant tamoxifen.
Meattini I; Livi L; Saieva C; Franceschini D; Scotti V; Mangoni M; Loi M; Di Brina L; Zei G; Bonomo P; Greto D; Gelain E; Nori J; Sanchez LJ; Orzalesi L; Bianchi S; Biti G
Clin Breast Cancer; 2013 Aug; 13(4):247-53. PubMed ID: 23684167
[TBL] [Abstract][Full Text] [Related]
18. Relationship between ultrasound features of nonalcoholic fatty liver disease and cardiometabolic risk factors in patients with newly diagnosed type 2 diabetes.
Kosmalski M; Kasznicki J; Drzewoski J
Pol Arch Med Wewn; 2013; 123(9):436-42. PubMed ID: 23792440
[TBL] [Abstract][Full Text] [Related]
19. Nonalcoholic fatty liver disease is associated with breast cancer in nonobese women.
Kwak MS; Yim JY; Yi A; Chung GE; Yang JI; Kim D; Kim JS; Noh DY
Dig Liver Dis; 2019 Jul; 51(7):1030-1035. PubMed ID: 30686716
[TBL] [Abstract][Full Text] [Related]
20. Goserelin plus tamoxifen compared to chemotherapy followed by tamoxifen in premenopausal patients with early stage-, lymph node-negative breast cancer of luminal A subtype.
Alramadhan M; Ryu JM; Rayzah M; Nam SJ; Kim SW; Yu J; Lee SK; Bae SY; Park S; Paik HJ; Lee JE
Breast; 2016 Dec; 30():111-117. PubMed ID: 27697675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
